Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

514 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unanswered questions in prostate cancer - findings of an international multi-stakeholder consensus by the PIONEER consortium.
Omar MI, MacLennan S, Ribal MJ, Roobol MJ, Dimitropoulos K, van den Broeck T, MacLennan SJ, Axelsson SE, Gandaglia G, Willemse PP, Mastris K, Ransohoff JB, Devecseri Z, Abbott T, De Meulder B, Bjartell A, Asiimwe A, N'Dow J; PIONEER Consortium. Omar MI, et al. Among authors: gandaglia g. Nat Rev Urol. 2023 Aug;20(8):494-501. doi: 10.1038/s41585-023-00748-9. Epub 2023 Apr 3. Nat Rev Urol. 2023. PMID: 37012441 Review.
A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) Methodology.
Ratti MM, Gandaglia G, Sisca ES, Derevianko A, Alleva E, Beyer K, Moss C, Barletta F, Scuderi S, Omar MI, MacLennan S, Williamson PR, Zong J, MacLennan SJ, Mottet N, Cornford P, Aiyegbusi OL, Van Hemelrijck M, N'Dow J, Briganti A. Ratti MM, et al. Among authors: gandaglia g. Cancers (Basel). 2022 Oct 19;14(20):5120. doi: 10.3390/cancers14205120. Cancers (Basel). 2022. PMID: 36291905 Free PMC article. Review.
Re: Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 Guideline.
Gandaglia G, Briganti A, Chiti A, Cozzarini C, Montorsi F. Gandaglia G, et al. Eur Urol Oncol. 2023 May 12:S2588-9311(23)00077-9. doi: 10.1016/j.euo.2023.04.001. Online ahead of print. Eur Urol Oncol. 2023. PMID: 37183078 No abstract available.
Impact of the time elapsed between prostate biopsy and surgery on the accuracy of nomograms predicting lymph node invasion in patients with clinically localized prostate cancer.
Pellegrino F, Mazzone E, Stabile A, Beauval JB, Marra G, Campi R, Afferi L, Zhuang J, Sorce G, Rosiello G, Barletta F, Scuderi S, Guo H, Gontero P, Minervini A, Ploussard G, Montorsi F, Briganti A, Gandaglia G. Pellegrino F, et al. Among authors: gandaglia g. Urol Oncol. 2023 Sep;41(9):387.e17-387.e25. doi: 10.1016/j.urolonc.2023.04.019. Epub 2023 May 16. Urol Oncol. 2023. PMID: 37198026
Re: Jakob Klemm, Michael Rink, Markus von Deimling, et al. Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized Reporting. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.06.005.
Montorsi F, Moschini M, Gandaglia G, Briganti A. Montorsi F, et al. Among authors: gandaglia g. Eur Urol Focus. 2023 Sep 23:S2405-4569(23)00206-7. doi: 10.1016/j.euf.2023.09.008. Online ahead of print. Eur Urol Focus. 2023. PMID: 37748951 No abstract available.
The impact of a second MRI and re-biopsy in patients with initial negative mpMRI-targeted and systematic biopsy for PIRADS ≥ 3 lesions.
Zattoni F, Pereira LJP, Marra G, Valerio M, Olivier J, Puche-Sanz I, Rajwa P, Maggi M, Campi R, Amparore D, De Cillis S, Junlong Z, Guo H, La Bombarda G, Fuschi A, Veccia A, Ditonno F, Marquis A, Barletta F, Leni R, Serni S, Kasivisvanathan V, Antonelli A, Dal Moro F, Rivas JG, van den Bergh RCN, Briganti A, Gandaglia G, Novara G. Zattoni F, et al. Among authors: gandaglia g. World J Urol. 2023 Nov;41(11):3357-3366. doi: 10.1007/s00345-023-04578-7. Epub 2023 Sep 27. World J Urol. 2023. PMID: 37755520 Free PMC article.
Re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.010.
Montorsi F, Rosiello G, Gandaglia G, Salonia A, Briganti A. Montorsi F, et al. Among authors: gandaglia g. Eur Urol Oncol. 2023 Nov 9:S2588-9311(23)00237-7. doi: 10.1016/j.euo.2023.10.020. Online ahead of print. Eur Urol Oncol. 2023. PMID: 37951819 No abstract available.
A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer.
Slevin F, Zattoni F, Checcucci E, Cumberbatch MGK, Nacchia A, Cornford P, Briers E, De Meerleer G, De Santis M, Eberli D, Gandaglia G, Gillessen S, Grivas N, Liew M, Linares Espinós EE, Oldenburg J, Oprea-Lager DE, Ploussard G, Rouvière O, Schoots IG, Smith EJ, Stranne J, Tilki D, Smith CT, Van Den Bergh RCN, Van Oort IM, Wiegel T, Yuan CY, Van den Broeck T, Henry AM. Slevin F, et al. Among authors: gandaglia g. Eur Urol Oncol. 2023 Dec 26:S2588-9311(23)00284-5. doi: 10.1016/j.euo.2023.11.018. Online ahead of print. Eur Urol Oncol. 2023. PMID: 38151440 Free article. Review.
514 results